Two recent updates for psychiatric conditions.
R R
RR
Silva
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000069445:Atomoxetine Hydrochloride; D001552:Benzazepines / Q000009:adverse effects* / Q000627:therapeutic use; D016642:Bupropion / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D003226:Congresses as Topic; D004348:Drug Labeling; D006801:Humans; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D011437:Propylamines / Q000009:adverse effects*; D011810:Quinoxalines / Q000009:adverse effects* / Q000627:therapeutic use; D016540:Smoking Cessation / Q000379:methods; D013405:Suicide / Q000523:psychology*; D014481:United States; D014486:United States Food and Drug Administration; D000068580:Varenicline
D001552:Benzazepines; D011437:Propylamines; D011810:Quinoxalines; D016642:Bupropion; D000069445:Atomoxetine Hydrochloride; D000068580:Varenicline